NOTE 5 – RELATED PARTY TRANSACTIONS |
12 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Related Party Transactions [Abstract] | |
| NOTE 5 – RELATED PARTY TRANSACTIONS | NOTE 5 – RELATED PARTY TRANSACTIONS
The Company purchased assets from the Company’s current Chief Executive Officer (“CEO”) and Secretary/Treasurer. (See note 6).
On June 10, 2023, the Company has entered into an agreement with Woundcare Labs, LLC, a party related to the CEO of the Company, to lease a plant and to lease equipment in Tennessee (see note 8).
Related Party Advances
The Company’s Chief Executive Office advanced $9,962 and $3,490 to the Company during the years ended March 31, 2025 and 2024, respectively, to pay for operating expenses. The related party advances total $13,652 and $3,690 as of March 31, 2025, and March 31, 2024, respectively. Related party advances are unsecured, non-interest bearing and due on demand.
Related Party Notes Payable
During the years ended March 31, 2025 and 2024 the Company’s CEO advanced the Company monies for operating expenses in the amount of $284,460 and $120,000, respectively, in various amounts with multiple notes. As of March 31, 2025, these have been consolidated into one Note for $306,103. This note is unsecured and bears interest at ten (10) percent per annum with principal and interest due six months after the date of issue. The note is due September 30, 2025.
Repayment during the years ended March 31, 2025 and 2024 was $113,628 and $47,500, respectively. The related interest expense during the years ended March 31, 2025 and 2024 was $21,946 and $4,934, respectively.
|